{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:03:20Z","timestamp":1784822600584,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40120-026-00954-8","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:53:31Z","timestamp":1778756011000},"page":"2189-2196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric Radiologically Isolated Syndrome (RIS): A Case with Active Disease 18\u00a0Years Later"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9794-6481","authenticated-orcid":false,"given":"Angelo","family":"Ghezzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Pozzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Annovazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Antozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Erbetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Torri Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"9","key":"954_CR1","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/01.wnl.0000335764.14513.1a","volume":"72","author":"DT Okuda","year":"2009","unstructured":"Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009;72(9):800\u20135. https:\/\/doi.org\/10.1212\/01.wnl.0000335764.14513.1a. (Erratum in: Neurology; 2009 Apr 7;72(14):1284.)","journal-title":"Neurology"},{"issue":"2","key":"954_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ana.25799","volume":"88","author":"C Lebrun-Frenay","year":"2020","unstructured":"Lebrun-Frenay C, Kantarci OS, et al. Radiologically isolated syndrome: 10-year risk estimate of a clinical event. Ann Neurol. 2020;88(2):407\u201317. https:\/\/doi.org\/10.1002\/ana.25799.","journal-title":"Ann Neurol"},{"issue":"10","key":"954_CR3","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","volume":"24","author":"X Montalban","year":"2025","unstructured":"Montalban X, Lebrun-Fr\u00e9nay C, Oh J, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(25)00270-4. (Erratum in: Lancet Neurol. 2025 Nov;24(11):e13, 10.1016\/S1474-4422(25)00355-2).","journal-title":"Lancet Neurol"},{"key":"954_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.msard.2018.06.010","volume":"24","author":"C Wilbur","year":"2018","unstructured":"Wilbur C, Yeh EA. Radiologically isolated syndrome in children: current knowledge and future directions. Mult Scler Relat Disord. 2018;24:79\u201384. https:\/\/doi.org\/10.1016\/j.msard.2018.06.010.","journal-title":"Mult Scler Relat Disord"},{"issue":"10","key":"954_CR5","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.neurol.2025.09.005","volume":"181","author":"D Ripsman","year":"2025","unstructured":"Ripsman D, Tremlett H, Alzahrani A, Makhani N. Disease modifying treatment of radiologically isolated syndrome: a systematic review of the use, efficacy, effectiveness, and safety. Rev Neurol (Paris). 2025;181(10):955\u201369. https:\/\/doi.org\/10.1016\/j.neurol.2025.09.005.","journal-title":"Rev Neurol (Paris)"},{"key":"954_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1145260","volume":"14","author":"E Barbuti","year":"2023","unstructured":"Barbuti E, Nistri R, Ianniello A, et al. Should we treat pediatric radiologically isolated syndrome? An 18-year follow-up case report. Front Neurol. 2023;14:1145260. https:\/\/doi.org\/10.3389\/fneur.2023.1145260.","journal-title":"Front Neurol"},{"issue":"6","key":"954_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10654-006-9022-0","volume":"21","author":"VW Jaddoe","year":"2006","unstructured":"Jaddoe VW, Mackenbach JP, Moll HA. The Generation R Study: design and cohort profile. Eur J Epidemiol. 2006;21(6):475\u201384. https:\/\/doi.org\/10.1007\/s10654-006-9022-0.","journal-title":"Eur J Epidemiol"},{"key":"954_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106538","volume":"100","author":"C Tzempetzis","year":"2025","unstructured":"Tzempetzis C, Tsimakidi C, Gkougka D, Gontika M. Pediatric radiologically isolated syndrome and multiple sclerosis prodrome: a case report and review of the literature. Mult Scler Relat Disord. 2025;100:106538. https:\/\/doi.org\/10.1016\/j.msard.2025.106538.","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"954_CR9","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/ana.25247","volume":"83","author":"G Disanto","year":"2018","unstructured":"Disanto G, Zecca C, MacLachlan S, Sacco R, et al. Prodromal symptoms of multiple sclerosis in primary care. Ann Neurol. 2018;83(6):1162\u201373. https:\/\/doi.org\/10.1002\/ana.25247.","journal-title":"Ann Neurol"},{"issue":"1","key":"954_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/2055217319836664","volume":"5","author":"N Makhani","year":"2019","unstructured":"Makhani N, Lebrun C, Siva A, et al. Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome. Mult Scler J Exp Transl Clin. 2019;5(1):2055217319836664. https:\/\/doi.org\/10.1177\/2055217319836664.","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"2","key":"954_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.24953\/turkjped.2020.02.010","volume":"62","author":"G Bekta\u015f","year":"2020","unstructured":"Bekta\u015f G, \u00d6zkan MU, Y\u0131ld\u0131z EP, et al. Clinically isolated syndrome and multiple sclerosis in children: a single center study. Turk J Pediatr. 2020;62(2):244\u201351. https:\/\/doi.org\/10.24953\/turkjped.2020.02.010.","journal-title":"Turk J Pediatr"},{"key":"954_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104573","volume":"71","author":"V Bhise","year":"2023","unstructured":"Bhise V, Waltz M, Casper TC, et al. Silent findings: examination of asymptomatic demyelination in a pediatric US cohort. Mult Scler Relat Disord. 2023;71:104573. https:\/\/doi.org\/10.1016\/j.msard.2023.104573.","journal-title":"Mult Scler Relat Disord"},{"key":"954_CR13","doi-asserted-by":"publisher","first-page":"e232815","DOI":"10.1001\/jamaneurol.2023.2815","volume":"21","author":"C Lebrun-Frenay","year":"2023","unstructured":"Lebrun-Frenay C, Siva A, Sormani MP, et al. Teriflunomide and time to clinical multiple sclerosis in patients with radiologically isolated syndrome: the TERIS Randomized Clinical Trial. JAMA Neurol. 2023;21:e232815. https:\/\/doi.org\/10.1001\/jamaneurol.2023.2815.","journal-title":"JAMA Neurol"},{"issue":"3","key":"954_CR14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ana.26555","volume":"93","author":"DT Okuda","year":"2023","unstructured":"Okuda DT, Kantarci O, Lebrun-Fr\u00e9nay C, et al. Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome. Ann Neurol. 2023;93(3):604\u201314. https:\/\/doi.org\/10.1002\/ana.26555.","journal-title":"Ann Neurol"},{"issue":"7","key":"954_CR15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s40263-019-00647-x","volume":"33","author":"M F\u00f6rster","year":"2019","unstructured":"F\u00f6rster M, Graf J, Mares J, et al. Drug treatment of clinically isolated syndrome. CNS Drugs. 2019;33(7):659\u201376. https:\/\/doi.org\/10.1007\/s40263-019-00647-x.","journal-title":"CNS Drugs"},{"issue":"4","key":"954_CR16","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s40120-024-00633-6","volume":"13","author":"A Ghezzi","year":"2024","unstructured":"Ghezzi A. Old and new strategies in the treatment of pediatric multiple sclerosis: a personal view for a new treatment approach. Neurol Ther. 2024;13(4):949\u201363. https:\/\/doi.org\/10.1007\/s40120-024-00633-6.","journal-title":"Neurol Ther"},{"key":"954_CR17","doi-asserted-by":"publisher","first-page":"e000215","DOI":"10.1136\/bmjno-2021-000215","volume":"4","author":"L Krupp","year":"2022","unstructured":"Krupp L, Banwell B, Chitnis T, et al. Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase\u00a03 PARADIGMS Study. BMJ Neurol Open. 2022;4:e000215. https:\/\/doi.org\/10.1136\/bmjno-2021-000215.","journal-title":"BMJ Neurol Open"},{"issue":"11","key":"954_CR18","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1007\/s10072-022-06211-8","volume":"43","author":"D Baroncini","year":"2022","unstructured":"Baroncini D, Ghezzi A, Guaschino C, et al. Long-term follow-up (up to 11\u00a0years) of an Italian pediatric MS cohort treated with natalizumab: a multicenter, observational study. Neurol Sci. 2022;43(11):6415\u201323. https:\/\/doi.org\/10.1007\/s10072-022-06211-8. (Epub 2022 Jul 4; PMID: 35781765).","journal-title":"Neurol Sci"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-00954-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-026-00954-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-00954-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:11:20Z","timestamp":1784819480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-026-00954-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["954"],"URL":"https:\/\/doi.org\/10.1007\/s40120-026-00954-8","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ghezzi Angelo is an Editorial Board member of\n                      Neurology and Therapy\n                      . Angelo Ghezzi was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Pozzato Mattia received honoraria for lecturing and\/or travel expenses for attending congresses and meetings from Alexion, Amgen, Biogen, Bristol Meyer Squibb, Janssen, Juvis\u00e8, Lundbeck, Merck, Novartis, Neuraxpharm, Roche and Sanofi-Genzyme. Annovazzi Pietro received honoraria for lecturing and participation in advisory boards, and\/or travel expenses for attending congresses and meetings from Alexion, Almirall, Amgen, Biogen, Bristol Meyer Squibb, Janssen, Juvis\u00e8, Lundbeck, Merck, Novartis, Neuraxpharm, Roche, Sanofi-Genzyme and Viatris. Antozzi Carlo received funding for travel, meeting attendance and advisory board participation from Alexion, Momenta, argenx, UCB and Johnson & Johnson. Erbetta Alessandra has nothing to disclose. Torri Clerici Valentina acted as an Advisory Board member of\u00a0Neuraxapharm, Lundbeck, Amgen, Novartis, Merck, Roche, Sanofi and Almirall and received funding for traveling and honoraria for speaking or writing from Biogen, Novartis, Sanofi, Merck, Amgen, Roche, Alexion, Neuraxapharm, Janssen, Bristol Meyer Squibb and Almirall. She received support for research project by Almirall.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient gave her consent to publish data concerning her clinical history.","order":2,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}